Michael D. Taylor
2019
In 2019, Michael D. Taylor earned a total compensation of $5.2M as Former President and Chief Executive Officer at Deciphera Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $20,405 |
|---|---|
| Option Awards | $4,589,482 |
| Salary | $396,667 |
| Other | $174,533 |
| Total | $5,181,087 |
Taylor received $4.6M in option awards, accounting for 89% of the total pay in 2019.
Taylor also received $20.4K in non-equity incentive plan, $396.7K in salary and $174.5K in other compensation.
Rankings
In 2019, Michael D. Taylor's compensation ranked 2,096th out of 13,971 executives tracked by ExecPay. In other words, Taylor earned more than 85.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,096 out of 13,971 | 85th |
Division Manufacturing | 762 out of 5,701 | 87th |
Major group Chemicals And Allied Products | 234 out of 2,200 | 89th |
Industry group Drugs | 189 out of 1,886 | 90th |
Industry Pharmaceutical Preparations | 136 out of 1,398 | 90th |
Source: SEC filing on April 24, 2020.
Taylor's colleagues
We found four more compensation records of executives who worked with Michael D. Taylor at Deciphera Pharmaceuticals in 2019.